Asset vs asset
OKB is a exchange-linked market proxy with $1.8B in market cap, while Injective is a INJ market beta asset with $303.19M. The useful comparison is market role, liquidity, seven-day direction, and which follow-up page gives the cleaner next decision.
Comparison Table
| Question | OKB | Injective |
|---|---|---|
| Market role | exchange-linked market proxy | INJ market beta asset |
| Price | $85.92 | $3.03 |
| Market cap | $1.8B | $303.19M |
| 24h volume | $16.53M | $38.31M |
| 7d change | -6.98% | -1.11% |
| Relative size | OKB is 5.95x Injective's market cap | Injective is 0.17x OKB's market cap |
| Volume comparison | OKB trades at 0.43x Injective's 24h volume | Injective trades at 2.32x OKB's 24h volume |
Use the market-cap calculator when the real question is what one asset would imply at another size.
Open calculatorA cleaner comparison still needs a practical plan for exchanges, withdrawals, and wallets.
Open checklistPut both names back into the wider market context before treating the comparison as a final answer.
Open markets